Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.

@article{Binet2006PerspectivesOT,
  title={Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.},
  author={J. P. Binet and Federico Caligaris-Cappio and Daniel Catovsky and Bruce D Cheson and Tom Newsom Davis and Guillaume Dighiero and Hartmut D{\"o}hner and Michael J Hallek and Peter Hillmen and Michael J Keating and Emili Montserrat and Thomas J. Kipps and Kanti R Rai},
  journal={Blood},
  year={2006},
  volume={107 3},
  pages={859-61}
}
Recently, considerable progress has been made in the identification of molecular and cellular markers that may predict the tendency for disease progression in patients with chronic lymphocytic leukemia (CLL) or detect minimal residual disease after therapy. These developments have created uncertainty for clinicians who hope to incorporate the use of these markers and new disease-assessment tools into standard clinical practice. However, clinical trials are required to determine whether poor… CONTINUE READING

From This Paper

Topics from this paper.
71 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

Similar Papers

Loading similar papers…